The grant application was likely with regard to the lung cell test. The exciting question is are they proposing phase 2 human trials for the grant money. With these results and Brilicidin's safety profile I wouldn't be surprised if they skip the Rhesus monkeys and go straight into the clinic.

Go IPIX!